Bio-Techne (TECH) Income from Non-Controlling Interests (2020 - 2022)

Bio-Techne (TECH) recorded quarterly Income from Non-Controlling Interests of $179000.0 in Q3 2022, down 54.22% quarter-over-quarter from $391000.0 in Q2 2022, and up 128.23% on a YoY basis from $78428.5 in Q3 2021.

Bio-Techne (TECH) Income from Non-Controlling Interests (2020 - 2022) Analysis & Trends

Bio-Techne's Income from Non-Controlling Interests history runs 3 years deep, the most recent figure standing at $179000.0 for Q3 2022.

  • In Q3 2022, Income from Non-Controlling Interests rose 128.23% year-over-year to $179000.0; the TTM figure through Jun 2023 stood at $179000.0 (up 102.0% YoY), while the FY2023 annual figure was $179000.0, up 102.0% from the prior year.
  • Income from Non-Controlling Interests was $179000.0 for Q3 2022 at Bio-Techne, down from $391000.0 in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of $391000.0 in Q2 2022 to a low of -$8.1 million in Q4 2021.
  • Historically, Income from Non-Controlling Interests has averaged -$1.2 million across 3 years, with a median of -$348000.0 in 2021.
  • The sharpest annual moves came in 2021 and 2022: Income from Non-Controlling Interests slumped 6141.54% in 2021, then soared 223.73% in 2022.
  • A 3-year view of Income from Non-Controlling Interests shows it stood at -$130000.0 in 2020, then plunged by 6141.54% to -$8.1 million in 2021, then soared by 102.21% to $179000.0 in 2022.
  • The last three Income from Non-Controlling Interests figures came in at $179000.0 (Q3 2022), $391000.0 (Q2 2022), and -$595000.0 (Q1 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -13.75 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Bio-Techne 9.04 Bn 8.83 Bn 208.29 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2022 179,000.00
Jun 30, 2022 391,000.00
Mar 31, 2022 -595,000.00
Dec 31, 2021 -8.11 Mn
Sep 30, 2021 -634,000.00
Jun 30, 2021 -316,000.00
Mar 31, 2021 -380,000.00
Dec 31, 2020 -130,000.00